Cargando…
1983. Oral Therapy with Rifampin Associated with Minocycline or Moxifloxacin in Vertebral Osteomyelitis due to Gram-Positive Micro-organisms: A Retrospective Study of 64 Cases
BACKGROUND: IDSA guidelines about vertebral osteomyelitis (VO) recommend parenteral antimicrobial therapy (PAT) as the standard treatment for Gram-positive pathogens (GPP). In this setting, a switch to oral antimicrobial therapy (OAT) with excellent bioavailability could be considered. However, amon...
Autores principales: | Gaspard, Laura, Giot, Jean-Baptiste, Moutschen, Michel, Frippiat, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253707/ http://dx.doi.org/10.1093/ofid/ofy210.1639 |
Ejemplares similares
-
Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
por: Lenz, Shannon M., et al.
Publicado: (2020) -
Novel approaches in the treatment of Hansen’s disease (Leprosy): a
case series of multidrug therapy of monthly rifampin, moxifloxacin, and
minocycline (RMM) in the United States
por: Franco-Paredes, Carlos, et al.
Publicado: (2022) -
Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
por: She, Pengfei, et al.
Publicado: (2022) -
Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017
por: Darcis, Gilles, et al.
Publicado: (2018) -
Sensitization of Gram-negative bacteria to rifampin and OAK combinations
por: Jammal, Joanna, et al.
Publicado: (2015)